These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
924 related articles for article (PubMed ID: 33013929)
1. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19. Xu W; Wang M; Yu D; Zhang X Front Immunol; 2020; 11():565278. PubMed ID: 33013929 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2. Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372 [TBL] [Abstract][Full Text] [Related]
3. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841 [TBL] [Abstract][Full Text] [Related]
4. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens. Vashi Y; Jagrit V; Kumar S Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352 [TBL] [Abstract][Full Text] [Related]
5. Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach. Naz A; Shahid F; Butt TT; Awan FM; Ali A; Malik A Front Immunol; 2020; 11():1663. PubMed ID: 32754160 [TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2). Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882 [TBL] [Abstract][Full Text] [Related]
7. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Liu L; Wang P; Nair MS; Yu J; Rapp M; Wang Q; Luo Y; Chan JF; Sahi V; Figueroa A; Guo XV; Cerutti G; Bimela J; Gorman J; Zhou T; Chen Z; Yuen KY; Kwong PD; Sodroski JG; Yin MT; Sheng Z; Huang Y; Shapiro L; Ho DD Nature; 2020 Aug; 584(7821):450-456. PubMed ID: 32698192 [TBL] [Abstract][Full Text] [Related]
8. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related]
9. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359 [TBL] [Abstract][Full Text] [Related]
10. Designing an efficient multi-epitope vaccine displaying interactions with diverse HLA molecules for an efficient humoral and cellular immune response to prevent COVID-19 infection. Mahapatra SR; Sahoo S; Dehury B; Raina V; Patro S; Misra N; Suar M Expert Rev Vaccines; 2020 Sep; 19(9):871-885. PubMed ID: 32869699 [TBL] [Abstract][Full Text] [Related]
12. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein. Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801 [TBL] [Abstract][Full Text] [Related]
14. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Li Y; Lai DY; Zhang HN; Jiang HW; Tian X; Ma ML; Qi H; Meng QF; Guo SJ; Wu Y; Wang W; Yang X; Shi DW; Dai JB; Ying T; Zhou J; Tao SC Cell Mol Immunol; 2020 Oct; 17(10):1095-1097. PubMed ID: 32895485 [No Abstract] [Full Text] [Related]
15. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country. Requena D; Médico A; Chacón RD; Ramírez M; Marín-Sánchez O Front Immunol; 2020; 11():2008. PubMed ID: 33013857 [TBL] [Abstract][Full Text] [Related]
16. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. Banerjee A; Santra D; Maiti S J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788 [TBL] [Abstract][Full Text] [Related]
17. Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome. Crooke SN; Ovsyannikova IG; Kennedy RB; Poland GA Sci Rep; 2020 Aug; 10(1):14179. PubMed ID: 32843695 [TBL] [Abstract][Full Text] [Related]
18. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach. Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041 [TBL] [Abstract][Full Text] [Related]
19. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review. Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296 [TBL] [Abstract][Full Text] [Related]
20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]